The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)
Aging · 2023
DOI: 10.18632/aging.204942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Qiulu Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530000, P.R. China. Hauptthemen laut MEDLINE: Brain Neoplasms, Radiotherapy, Intensity-Modulated, Glioma. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530000, P.R. China.
- Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530000, P.R. China.
- Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, Guangxi 530000, P.R. China.
Zitieren
APA
Zhong, Q., Luo, D., Chen, D., Li, X., Du, Q., Liang, Q., Li, J., & Zhu, X. (2023). The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT). Aging. https://doi.org/10.18632/aging.204942
Vancouver
Zhong Q, Luo D, Chen D, Li X, Du Q, Liang Q, et al. The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT). Aging. 2023. doi:10.18632/aging.204942
BibTeX
@article{Zhong2023,
author = {Zhong, Qiulu and Luo, Danjing and Chen, Da and Li, Xiangde and Du, Qinghua and Liang, Qianfu and Li, Jian and Zhu, Xiaodong},
title = {The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204942}
}
EUVIMED